Floatz logo

281 assets in Gastric Cancer

Therapeutic assets addressing Gastric Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Bgb-43395
Gastric Cancer
BeiGeneP1C (37)
Bl-M07D1
Gastric Cancer
SystImmune Inc.P1C (37)
Bl-M17D1
Gastric Cancer
SystImmune Inc.P1C (37)
Cadvec
Gastric Cancer
Baylor College of MedicineP1C (37)
cct303-406
Gastric Cancer
Shanghai PerHum Therapeutics Co., Ltd.P1C (37)
Cirtociclib
Gastric Cancer
Blueprint Medicines CorporationP1C (37)
Claudin 18.2 Car-T
Gastric Cancer
Suzhou Immunofoco Biotechnology Co., LtdP1C (37)
cpo102
Gastric Cancer
Conjupro Biotherapeutics, Inc.P1C (37)
CRX100
Gastric Cancer
BioEclipse TherapeuticsP1C (37)
Dat-2645
Gastric Cancer
Danatlas Pharmaceuticals Co., LtdP1C (37)
dr-0202
Gastric Cancer
Dren BioP1C (37)
Emunkitug
Gastric Cancer
HiFiBiO TherapeuticsP1C (37)
exs74539
Gastric Cancer
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.P1C (37)
Fpi-2053
Gastric Cancer
AstraZenecaP1C (37)
hfb200603
Gastric Cancer
HiFiBiO TherapeuticsP1C (37)
H-Gamma1 Heavy Chain Humanized (1-449) [Vh (Homo Sapiens Ighv3-23*01 (81.6%) -(Ighd) -Ighj3*02 (91.7%) M123>T (114), Cdr-Imgt [8.7.13] (26-33.51-57.96-108)) (1-119) -Homo Sapiens Ighg1*03V (100%) G1M3>G1M17, Ng1M1 Ch1 K120, Ch3 E12, M14 (Ch1 R120>K (216) (120-217), Hinge 1-15 (218-232), Ch2 (233-342), Ch3 E12 (358), M14 (360) (343-447), Chs (448-449)) (120-449)], (222-218')-Disulfide With L-Kappa Light Chain Humanized (1'-218') [Vkappa (Homo Sapiens Igkv1-33*01 (87.8%) -Igkj4*01 (100%), Cdr-Imgt [6.3.13] (27'-32'.50'-52'.89'-101')) (1'-111')-Homo Sapiens Igkc*01 (100%) Km3 A45.1, V101 (C-Kappaa45.1 (157'), V101 (195')) (112'-218')]; Dimer (228-228'':231-231'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Cell Line Cho-K1, Glycoform Alfa
Gastric Cancer
Genentech, Inc.P1C (37)
Idov-Immune
Gastric Cancer
ViroMissile, Inc.P1C (37)
iks014
Gastric Cancer
Iksuda Therapeutics Ltd.P1C (37)
Immunoglobulin G1 [De-236-Glycine,267-Glutamic Acid,De-C-Terminal Lysine], Anti-(Human Tumor Necrosis Factor Receptor Tnfrsf9) (Human-Mus Musculus Monoclonal Lvgn6051 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Lvgn6051 ?-Chain, Dimer
Gastric Cancer
M.D. Anderson Cancer CenterP1C (37)
Immunoglobulin G1 [De-236-Glycine,De-C-Terminal Lysine], Anti-(Human Cd40 Antigen) (Human Monoclonal Lvgn7409 ?1-Chain), Disulfide With Human Monoclonal Lvgn7409 ?-Chain, Dimer
Gastric Cancer
M.D. Anderson Cancer CenterP1C (37)
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Tigit (T-Cell Immunoreceptor With Ig Domain And Itim, V-Set Ig Member 9, Vsig9, V-Set And Transmembrane Member 3, Vstm3)], Humanized Monoclonal Antibody; Gamma1 Heavy Chain Humanized (1-448) [Vh (Homo Sapiens Ighv3-48*01 (90.8%) -(Ighd) -Ighj4*01 (92.3%)) Cdr-Imgt [8.8.12] (26-33.51-58.97-108) (1-119) -Homo Sapiens Ighg1*01, G1M17,1, G1V14 Ch2 A1.3, A1.2 (Ch1 K120 (216) (120-217), Hinge 1-15 (218-232), Ch2 L1.3>A (236), L1.2>A (237) (233-342), Ch3 D12 (358), L14 (360) (343-447), Chs K>Del (448)) (120-448)], (222-214')-Disulfide With Kappa Light Chain Humanized (1'-214') [V-Kappa (Homo Sapiens Igkv1-16*01 (89.5%) -Igkj4*01 (100%)) Cdr-Imgt [6.3.9] (27-32.50-52.89-97) (1'-107') -Homo Sapiens Igkc*01 (100%) Km3 A45.1 (153), V101 (191) (108'-214')]; Dimer (228-228'':231-231'')-Bisdisulfide, Produced In A Chinese Hamster Ovary (Cho)-K1 Cell Line, Glycoform Alfa
Gastric Cancer
Taiho Pharmaceutical Co., Ltd.P1C (37)
ivx037
Gastric Cancer
ImmVirx Pty LtdP1C (37)
jr8603
Gastric Cancer
JiaRay GroupP1C (37)
Kk-Lc-1 Tcr-T Cells
Gastric Cancer
Christian HinrichsP1C (37)
lb1908
Gastric Cancer
Legend Biotech USA IncP1C (37)
MGC026
Gastric Cancer
MacroGenicsP1C (37)
Mnpr-101-Dfo-89Zr
Gastric Cancer
Monopar TherapeuticsP1C (37)
Mnpr-101-Pcta-177Lu
Gastric Cancer
Monopar TherapeuticsP1C (37)
Moma-341
Gastric Cancer
MOMA TherapeuticsP1C (37)
Monoclonal Antibody Trk-950
Gastric Cancer
Toray Industries, IncP1C (37)
mrg007
Gastric Cancer
ArriVent BioPharma, Inc.P1C (37)
ngm438
Gastric Cancer
NGM Biopharmaceuticals, IncP1C (37)
ngm831
Gastric Cancer
NGM Biopharmaceuticals, IncP1C (37)
nkt3447
Gastric Cancer
NiKang Therapeutics, Inc.P1C (37)
nkt3964
Gastric Cancer
NiKang Therapeutics, Inc.P1C (37)
pb101
Gastric Cancer
Panolos BioscienceP1C (37)
pf-07265028
Gastric Cancer
PfizerP1C (37)
pf-08046054
Gastric Cancer
Seagen, a wholly owned subsidiary of PfizerP1C (37)
Pimitespib
Gastric Cancer
Taiho Pharmaceutical Co., Ltd.P1C (37)
P-Muc1C-Allo1 Car-T Cells
Gastric Cancer
Poseida Therapeutics, Inc.P1C (37)
Pradusinstobart
Gastric Cancer
M.D. Anderson Cancer CenterP1C (37)
Ribociclib
Gastric Cancer
Blueprint Medicines CorporationP1C (37)
Rimiducid
Gastric Cancer
Poseida Therapeutics, Inc.P1C (37)
Rndo-564
Gastric Cancer
Rondo TherapeuticsP1C (37)
SAR443216
Gastric Cancer
SanofiP1C (37)
Son-Dp
Gastric Cancer
Qurgen Inc.P1C (37)
Stro-004
Gastric Cancer
Sutro Biopharma, Inc.P1C (37)
Tas-102
Gastric Cancer
Taiho Pharmaceutical Co., Ltd.P1C (37)
Tas-115
Gastric Cancer
Taiho Pharmaceutical Co., Ltd.P1C (37)
tj033721
Gastric Cancer
I-Mab Biopharma US LimitedP1C (37)
Showing 201 to 250 of 281 assets
PreviousPage 5 of 6Next